Michael Cloonan
Chief Executive Officer en Sionna Therapeutics, Inc. .
Perfil
Michael Cloonan es director de operaciones de SAGE Therapeutics, Inc. En el pasado ocupó el cargo de Vicepresidente Senior Comercial de Estados Unidos en Biogen, Inc. El Sr. Cloonan obtuvo un MBA en la Darden School of Business de la Universidad de Virginia y una licenciatura en el College of the Holy Cross (Massachusetts).
Cargos activos de Michael Cloonan
| Empresas | Cargo | Inicio |
|---|---|---|
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Consultant / Advisor | - |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Chief Executive Officer | - |
Antiguos cargos conocidos de Michael Cloonan.
| Empresas | Cargo | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chief Operating Officer | 03/05/2021 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2017 |
Formación de Michael Cloonan.
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Finance |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Health Services |
- Bolsa de valores
- Insiders
- Michael Cloonan
